Bison Capital Invests in Apex Innovative Sciences, Forming a National Clinical Trial Site Network
October 2, 2019
Bison Capital Partners V, LP announced a growth capital investment to form Apex Innovative Sciences, Inc., combining CNS Network and Hassman Research Institute and acquiring Clinical Trial Centers Alliance to create a national operator of clinical trial sites focused on central nervous system (CNS) indications. The new company operates multiple clinical research sites and Ocean View Psychiatric Hospital (a 36‑bed acute psychiatric hospital) to support Phase I–IV studies for pharmaceutical and biotech sponsors.
- Buyers
- Bison Capital Partners V, LP
- Targets
- Apex Innovative Sciences, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
CenExel Acquires Apex Innovative Sciences from Bison Capital
June 16, 2022
Healthcare Services
CenExel Clinical Research has acquired Apex Innovative Sciences, Inc. from Bison Capital Partners V, LP. The transaction adds Apex’s CNS-focused clinical research sites (including Collaborative Neuroscience Research and Hassman Research Institute) — five centers across California and New Jersey with substantial early‑phase and inpatient capacity — expanding CenExel’s neuroscience capabilities and geographic footprint.
-
PhaseWell Research Acquires Bio Behavioral Health
January 21, 2026
Healthcare Services
PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.
-
InTandem Capital Partners Invests in Clinilabs
March 12, 2025
Healthcare Services
InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.
-
Ampersand Capital Partners Invests in AnaBios Corporation
June 7, 2022
Healthcare Services
Ampersand Capital Partners has made a growth equity investment in San Diego-based AnaBios Corporation, a preclinical contract research organization specializing in translational research using human tissues. The investment will be used to expand AnaBios’s capabilities, therapeutic area coverage and global reach to support more successful drug discovery and development programs.
-
NMS-backed Flourish Research Recapitalizes Great Lakes Clinical Trials and Clinical Site Partners
January 12, 2022
Healthcare Services
NMS Capital portfolio company Flourish Research completed recapitalizations of Great Lakes Clinical Trials and Clinical Site Partners, expanding its multi-site clinical trial network across Illinois, Florida and Texas. The deals (terms undisclosed) add site capacity and management teams to Flourish Research as the platform pursues network consolidation, improved operational efficiencies and accelerated growth.
-
Behrman Capital Acquires Vista Apex from Inverness Graham
April 10, 2024
Dental
Behrman Capital has acquired Vista Apex, a Racine, Wisconsin-based manufacturer of dental consumables, from Inverness Graham. The transaction positions Behrman to grow Vista Apex's product portfolio, expand manufacturing and distribution capabilities, and pursue further strategic M&A to scale the business.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.